Covid-19 testing has been at the forefront of battling the pandemic. However, as the pandemic recedes and becomes more endemic, what will happen to the ever-changing COVID-19 testing market? The publisher answers this question and more in COVID-19 Testing Markets, 2023.
The pandemic has been a learning curve for all parties to invest in diagnostic systems, as COVID-19 aptly pointed out. Notably, the pandemic reinforced the importance of testing and a significant number of companies are increasing their development of a wide selection of diagnostic tests in all markets. Diagnostics have been critical in the response to COVID-19.
This report provides market sizing and estimates for COVID-19 tests with a discussion of the market impacts of COVID-19.
Some of the key topics and trends explored include:
- At-Home Testing
- Insurance Coverage
- Multiplex Testing
- Expiration of Public Health Emergency
- New Variants on the Horizon
- Immunoassay Testing
- Molecular Testing
Global Regional Analysis
The report’s global analysis features research, such as 2022-2027 sales estimates and forecasts, for regions and countries including:
- APAC
- Europe
- North America
- Rest of World
- Australia
- Austria
- Belgium
- Brazil
- Canada
- China
- Denmark
- France
- Germany
- India
- Italy
- Mexico
- Netherlands
- Japan
- Poland
- Romania
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Kingdom
- United States
Competitive Analysis
The report includes an analysis and profiles of key companies competing in this industry, including a breakout of the top competitors in the COVID-19 testing market based on 2022 manufacturer revenues.
Companies profiled include:
- Abbott
- Access Bio, Inc
- Becton-Dickinson
- BioMérieux
- Bio-Rad
- Cue Health
- Danaher corporation
- Diasorin
- ELITechGroup
- Genedrive plc
- Hologic
- LumiraDx UK
- OraSure Technologies
- PerkinElmer, Inc
- Qiagen
- QuantuMDx
- QuidelOrtho
- Roche Diagnostic Corporation
- Seegene
- Siemens Healthineers
- Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co)
- Thermo Fisher Scientific
Scope and Methodology
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews, in-person interviews and email correspondence were the primary methods of gathering information. For this study, the publisher conducted interviews with industry officials, consultants, healthcare providers, and government personnel. These sources were the primary basis for gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.
All market data pertains to the world market at the manufacturers’ level. The market includes manufacturer tests. The base year for data was 2022. Data are provided for 2022 and 2027 with compound annual growth rates (CAGRs) for 2022 and 2027. Competitive analysis is provided for the top ten participants in the market. Regional breakdowns are surveyed for North America, Europe, Asia-Pacific, and the Rest of the World. The forecasted market analysis through 2027 was largely based on demographic trends, new developments, the trajectory of COVID-19 and its variants, innovative technology and global use.
Table of Contents
Samples
LOADING...
Companies Mentioned
- Abbott Diagnostics
- Access Bio, Inc
- Beckman Coulter-Danaher
- Becton Dickinson
- Bio-Rad
- bioMérieux
- Cepheid-Danaher
- Cue Health
- Danaher Corporation
- DiaSorin S.p.A.
- ELITech Group S.A.S.
- Fujirebio Diagnostics
- Genedrive plc
- Hologic, Inc
- LumiraDx UK Limited
- OraSure Technologies, Inc.
- PerkinElmer, Inc
- QIAGEN N.V.
- QuantuMDx Group, Ltd.
- QuidelOrtho Corporation
- Roche Diagnostic Corporation
- Seegene, Inc
- Siemens Healthineers GmbH
- Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co)
- Thermo Fisher Scientific
